Skip to main content
Fig. 7 | BMC Bioinformatics

Fig. 7

From: In silico vaccine design and epitope mapping of New Delhi metallo-beta-lactamase (NDM): an immunoinformatics approach

Fig. 7

Immune simulation after two doses of vaccine introduction at first and 30th days and exposure to specific (ai-fi) or nonspecific (aii-fii) antigen on the 100th day. a antibody titer b B lymphocytes and sub-populations c B lymphocytes per state d Plasma B lymphocytes e T-helper lymphocytes f T-helper lymphocytes per state (for more details regarding Immune simulation refer to the “15-Immune simulation” in the methods section)

Back to article page